It is used for the treatment of diabetes mellitus type II.
Nausea, Increased amylase, Increased lipase, Diarrhea and Vomiting.
Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or in patients with multiple endocrine neoplasia syndrome type 2 (MEN-2)
Hypoglycemia may occur when used in combination with insulin secretagogues (eg, sulfonylureas) or insulin; consider lowering sulfonylurea or insulin dosage when starting dulaglutide
Inject this medication under the skin as directed by your doctor
Before injecting each dose, clean the injection site with rubbing alcohol. Change the injection site each time to lessen injury under the skin and to avoid developing problems under the skin (lipodystrophy).
Do not change brands or types of insulin without directions on how to do so from your doctor.
Please consult your doctor when taking this medicine if you are pregnant.
Some drugs that may interact with this drug are acarbose, canagliflozin, carbamazepine, ethosuximide, disopyramide, cyclosporine, dapagliflozin.